Skip to main content
. 2014 Oct 18;105(11):1457–1463. doi: 10.1111/cas.12532

Fig 3.

Fig 3

Hypermethylation-induced downregulation of YBX3 in the Cancer Genome Atlas Research Network acute myeloid leukemia cohort. (a) ZRSR2 and YBX3 promoters were hypermethylated in 7/173 (4.0%) and 11/173 (6.4%) acute myeloid leukemia cases, respectively. Promoter hypermethylation was not detected in other splicing factors. (b) YBX3 promoter hypermethylation was significantly associated with the loss of YBX3 mRNA expression (P < 0.0001). (c) Promoter hypermethylation of ZRSR2 was not associated with expression levels of ZRSR2 mRNA (P = 0.1204). RSEM, RNA-Seq by Expectation Maximization.